EXR110, EXR120, and Q8 Pro are positioned for CRP, HbA1c, vitamin D, thyroid, hormone, and cardiac-marker workflows where rapid decentralized testing shortens the clinical response cycle.
Relevant search terms include POCT hormone machine, CRP test analyzer, vitamin D rapid test, HbA1c analyzer, thyroid POCT, hormone reagent, and point-of-care immunoassay.
EXR110, EXR120, and Q8 Pro are positioned for CRP, HbA1c, vitamin D, thyroid, hormone, and cardiac-marker workflows where rapid decentralized testing shortens the clinical response cycle.
POCT and hormone testing solutions in Ethiopia based on Zybio EXR110, EXR120 and Q8 Pro.
A small fluorescence immunochromatography analyzer designed to provide rapid results in clinics, emergency departments and medium-to-small laboratory settings.
A similar compact POCT system with an 8-inch touchscreen, stable incubator and menu extending across cardiac, inflammation, diabetes, vitamin D, thyroid and sex hormone functions.
A larger POCT immunoassay platform positioned for laboratories and clinical departments needing broader channel capacity and faster multi-item workflow.
Key reasons this family matters during procurement, deployment planning, and technical review.
Designed for settings where turnaround time matters for cardiac, inflammation and metabolic testing.
POCT menu references include TSH, T3, T4 and sex-hormone related items depending on model and brochure menu.
Strong SEO alignment around routine high-interest analytes often searched by clinicians and procurement teams.
Relevant for clinics, emergency departments, ICU and other near-patient testing environments.
Quick comparison points used during technical review, model shortlisting, and quotation alignment.
Supports compact near-patient use through higher-capacity immunofluorescence workflow.
Useful for departments comparing one multifunction platform against several single-purpose devices.
Relevant where ward-side or emergency decision speed is a purchasing driver.
POCT is usually justified by access and speed, not only analyzer size.
How institutions usually frame this product family during department-level planning and quotation review.
cTnI, hs-cTnI, NT-proBNP, BNP, D-Dimer, CRP, PCT and IL-6 are represented in brochure menus.
HbA1c and 25-OH vitamin D feature in the menu context, strengthening diabetic and metabolic-use positioning.
TSH, T3, T4, FT3, FT4, AMH, HCG and FSH appear in the EXR/Q8 family menu materials.
Practical buying and deployment considerations frequently discussed during institutional evaluation.
Clarify whether the site needs emergency triage, outpatient screening, ICU support, or decentralized chronic-disease follow-up.
Shortlist platforms by actual analytes required in the tender rather than buying the largest general menu without workflow need.
LIS support, printer needs, reagent availability, and operator simplicity should be agreed before final quote comparison.
